The surgeon says not necessarily, and puts keeping results down to habits after surgery like diet, exercise and follow-up care.
Recap by typeshit. Post by @drcarlosmarciales on Instagram.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A quick list of foods like eggs, Greek yogurt, salmon, lentils and oats, which he says help with fullness and keeping muscle while losing weight.
He says the peptide has almost no human data and is only sold online as a research chemical, so both the compound and its sourcing carry unknown risks.
Biomea Fusion was set to release early results for its investigational obesity candidate on October 13, with shares at $1.44 in premarket trading.
Loading…